THEMIS
Study to Evaluate the Effect of Ticagrelor 90 mg Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.
PHASE: Follow Up (not taking new patients)
Principal Investigator:
Karen S. Sopko, MD, FACC
Sub-Investigators:
Brendan Cavanaugh, MD, FACC
Charles Kim, MD, FACC
Mel Peralta, MD, FACC
Barry Ramo, MD, FACC